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Dr. Berendes has necessarily taken a selective approach to his review of current
issues in perinatal epidemiology. I congratulate him on his selection ofissues; indeed, I
find I have embarrassingly little to disagree with in Dr. Berendes's presentation. My
comments, therefore, will attempt to expand discussion in three areas: (1) to consider
briefly some reporting and administrative requirements for the future of perinatal
epidemiology, (2) a comment on some definitional and theoretical developments, and
(3) a discussion of some technical and methodological problems currently facing
perinatal epidemiologists.
An important element of our work is that of routinely monitoring birth outcomes,
particularly perinatal mortality, fetal loss, and birth defects. In this country we do an
especially poor job of this type of surveillance. Dr. Berendes has identified some
problems in the quality ofthose data that are obtained, but our inability, in the United
States, to routinely link birth and death certificate data is a national scandal. Surely,
every modern society should be able to identify the outcome ofall its births, and, even
better, its pregnancies. This type of routine surveillance should become part of our
national data archive and should be financed from the National Center for Health
Statistics, not out ofresearch budgets.
With respect to the administration ofresearch itself, we should pay more attention
to understanding the administrative structures within which research can flourish. My
own bias, and I have no data to document this, in that the problem-oriented research
unit which cuts across traditional academicdepartments (and, incidentally, traditional
academic research methodologies) is the most productive arrangement. Ourcolleagues
at the National Perinatal Epidemiology Unit in Britain, and Dr. Berendes's own
program at the National Institute ofChild Health and Human Development, have led
the way. Universities pose their own unique difficulties in setting up research units, but
cancer epidemiologists in particular have gained useful experience here. Serious study
should be given to the development of administrative arrangements which permit the
optimum conduct ofepidemiologic research, especially within theuniversity, including
consideration ofthe funding and utilization ofcore staff, the integration ofstaffwithin
academic departments, and the problem of keeping a close relationship of research
staffto their parent disciplines.
The theoretical issue I wish to discuss concerns low birth weight. We now realize
that, in contrast to the Scandinavian countries, for example, the United States has
higher ratesoflow birth weight-not higher ratesofinfant mortality. That is, our birth
weight-specific perinatal mortality rates are comparable to other countries. This fact
has been a profoundly important observation, since it tells us where our future public
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health resources need to be focused: prenatally rather than postnatally, if a choice has
to be made.
However, I share Dr. Berendes's lack of enthusiasm for our interest in low birth
weight. Birth weight has the advantage of being easily measured but after that has
little use at all. What is of interest are those babies born before full term and those
babies born at term but suffering from growth retardation. The development of
epidemiologically valid measures of newborn maturity should be high on our research
agenda.
The problem of low birth weight among blacks highlights our confusion. A recent
Institute of Medicine Committee reported[1] that black neonates were at increased
risk oflow birth weight even after adjustment for 28 variables. If that committee had
been commissioned to investigate neonatal maturity rather than birth weight it, and
we, would have been more informed.
It has become increasingly evident that birth weight is genetically influenced (a not
unexpected revelation, since baby girls weigh on average some 100 g less than boys)
and genetic predisposition must account for a proportion of black/white differences in
low birth weight. The corollary of this statement must be that, at any given birth
weight, black(and female) neonates arerelatively more mature at birth than white (or
male) neonates. Support for this notion comes from the well-known (but misunder-
stood) observations that black (and female) neonates oflower weight experience lower
rates ofperinatal death than their white (male) counterparts. Consideration must be
given,therefore, to thedevelopment ofnational standards for neonatal maturity, which
arespecificallyappropriate for newborns ofdifferent genders and ethnic groups.
With respect to the increasing ability to detect when conception has occurred and,
consequently, when pregnancy has failed, this information will have a profound effect
on environmental studies. One does not have to be a member of this college to realize
the problem arising when the true population incidence of spontaneous abortion may
be three times what could previously be measured. The development of very early
pregnancy tests which can be easily and cheaply administered in large epidemiologic
studies could potentially lead to major advances in understanding the causes of
miscarriage and also many cases of what previously would have been diagnosed as
infertility. Since the great majority of early pregnancy losses are aneuploid [2],
surveillance of fetal loss as a screening device for potential carcinogens should also be
improved.
Reproductiveproblemsarising from conditions in theworkplace increasingly occupy
the attention of perinatal epidemiologists, and here too detection of early pregnancy
loss could become an important new outcome variable.
The methodological issue I wish to discuss concerns the use of randomized clinical
trials (RCTs). These are not new to perinatology. A recent compilation by the
National Perinatal Epidemiology Unit lists over 2,700 randomized perinatal trials
published between 1940 and 1984 [3]. Many ofthese RCTs provide conflicting results,
however, almostcertainly because oftheir small size and flaws in their design, conduct,
andanalysis. Majorimprovements arenecessary here. Dr. Berendes noted the need for
RCTs in newborn intensive care units but it is also noteworthy that many obstetrical
innovations also enjoy widespread use without ever having been properly evaluated.
Where uncertainty exists about the safety or efficacy of any established perinatal
maneuver, and whenanynew innovationisproposed,evaluationunder RCT conditions
should be mandatory. Nor should trials be restricted to technically sophisticated
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interventions. Delivery in a birthing chair [4] and a trial of the type of catgut used to
repair perineal trauma [5] are two recent examples of studies of procedures which
evaluate discomfort in the patient rather than serious medical risk. A more traditional
form ofstudywhich deserves renewed attention is theperinatal mortality audit. Recent
studies in Sweden [6] and Norway [7], which have imposed fairly rigorous methodolo-
gies on the auditing committee's decision-making process, indicate the valuable role
that a detailed review ofeach case can have in suggesting ways in which medical care
can be improved and also for developing hypotheses about possible causes ofperinatal
death which are amenable to more rigorous study. As perinatal mortality becomes a
rarerevent, the perinatal audit will become increasingly useful foridentifying potential
iatrogenic causes ofperinatal mortality.
Finally, a comment on antenatal ultrasound, a technology which, arguably, is having
the most profound effect on obstetric practice. We can be reassured about the
short-term safety ofultrasound on mother and child. Nonetheless, at some time within
the next ten years we will require studies ofpossible longer-term effects, when cohorts
ofthefirst recipients ofthis technology are old enough to be vulnerable to cancer. We
have every reason to expect these studies to be negative, but they must be done.
Whether or not ultrasound should be used routinely in pregnancy is now the subject
of some controversy in the United States, although it is already routinely offered in
some European countries [8]. Some RCTs havesuggested that multiple pregnancy and
intrauterine growth retardation can be diagnosed more readily, and managed more
easily, by routine ultrasonography, leading to some reduction in Cesarean sections and
post-term inductions. It is imperative that RCTs be launched in this country with
sufficiently large sample sizes to lay this matter to rest. Since the principal objections
to routine ultrasound include its inconvenience to the patient and its administrative
costs, these should be included as outcome measures. Other issues to be decided upon
are the cost effectiveness of a single ultrasound versus two examinations (usually
around 16 and 32 weeks gestational age) and whether routine ultrasound could replace
other perinatal screening programs such as alphafetoprotein for neural tube defects.
The technological development of the ultrasound machines themselves is moving so
rapidly that only the most advanced machines should be used in a trial, otherwise the
results will be irrelevant before the trial is even finished. This point is especially true if
routineultrasonography is considered as a screening tool forcongenital malformations.
Until recently, only gross malformations such as anencephaly could be visualized,
whereas now the upper lip, genitalia, and fetal kidneys are routinely studied [9].
Real-time machines even allow the diagnosis of fetal heart valve malformations long
before delivery. Malformations reflecting abnormal growth; e.g., microcephaly, limb
reduction defects, and dwarfism, are less readily diagnosed, and epidemiological
studies ofnormal, in utero growth ofall organs are necessary to provide this important
baseline data.
Again, I congratulate Dr. Berendes on his review. That both he and I have not had
time to comment on many other important issues in this field reflects its currentvitality
and augurs well for the next few years.
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